A new Tie1 targeted antibody blocks tumor cell extravasation and metastasis

by Kabir A Khan, Robert S Kerbel
Published 2020-06-01

Implications of vessel co-option in sorafenib-resistant hepatocellular carcinoma

by Elizabeth A. Kuczynski, Robert S. Kerbel
Published 2016-11-01

Development of Patient Derived Xenograft Models of Overt Spontaneous Breast Cancer Metastasis: A Cautionary Note.

by Marta Paez-Ribes, Shan Man, Ping Xu, Robert S Kerbel
Published 2016-01-01

Impact of Metronomic UFT/Cyclophosphamide Chemotherapy and Antiangiogenic Drug Assessed in a New Preclinical Model of Locally Advanced Orthotopic Hepatocellular Carcinoma

by Terence C. Tang, Shan Man, Christina R. Lee, Ping Xu, Robert S. Kerbel
Published 2010-03-01

Differential post-surgical metastasis and survival in SCID, NOD-SCID and NOD-SCID-IL-2Rγ(null) mice with parental and subline variants of human breast cancer: implications for host...

by Chloe C Milsom, Christina R Lee, Christina Hackl, Shan Man, Robert S Kerbel
Published 2013-01-01

Metronomic chemotherapy offsets HIFα induction upon maximum‐tolerated dose in metastatic cancers

by Luana Schito, Sergio Rey, Ping Xu, Shan Man, William Cruz‐Muñoz, Robert S Kerbel
Published 2020-09-01

Therapeutic impact of Nintedanib with paclitaxel and/or a PD-L1 antibody in preclinical models of orthotopic primary or metastatic triple negative breast cancer

by Elaine Reguera-Nuñez, Ping Xu, Annabelle Chow, Shan Man, Frank Hilberg, Robert S. Kerbel
Published 2019-01-01

Tumors That Acquire Resistance to Low-Dose Metronomic Cyclophosphamide Retain Sensitivity to Maximum Tolerated Dose Cyclophosphamide

by Urban Emmenegger, Giulio Francia, Annabelle Chow, Yuval Shaked, Andrew Kouri, Shan Man, Robert S. Kerbel
Published 2011-01-01

Development of a Resistance-like Phenotype to Sorafenib by Human Hepatocellular Carcinoma Cells Is Reversible and Can Be Delayed by Metronomic UFT Chemotherapy

by Terence C. Tang, Shan Man, Ping Xu, Giulio Francia, Kae Hashimoto, Urban Emmenegger, Robert S. Kerbel
Published 2010-11-01

Collateral Expression of Proangiogenic and Tumorigenic Properties in Intestinal Epithelial Cell Variants Selected for Resistance to Anoikis

by Janusz Rak, Yoshihiro Mitsuhashi, Cap Sheehan, Julia K. Krestow, Vivi Ann Florenes, Jorge Filmus, Robert S. Kerbel
Published 1999-04-01

Id1 restrains p21 expression to control endothelial progenitor cell formation.

by Alessia Ciarrocchi, Vladimir Jankovic, Yuval Shaked, Daniel J Nolan, Vivek Mittal, Robert S Kerbel, Stephen D Nimer, Robert Benezra
Published 2007-01-01

Suppressive impact of metronomic chemotherapy using UFT and/or cyclophosphamide on mediators of breast cancer dissemination and invasion.

by Raquel Muñoz, Denise Hileeto, William Cruz-Muñoz, Geoffrey A Wood, Ping Xu, Shan Man, Alicia Viloria-Petit, Robert S Kerbel
Published 2019-01-01

Microultrasound Molecular Imaging of Vascular Endothelial Growth Factor Receptor 2 in a Mouse Model of Tumor Angiogenesis

by Joshua J. Rychak, James Graba, Alison M.Y. Cheung, Bina S. Mystry, Jonathan R. Lindner, Robert S. Kerbel, F. Stuart Foster
Published 2007-09-01

Phosphorylated Epidermal Growth Factor Receptor on Tumor-Associated Endothelial Cells Is a Primary Target for Therapy with Tyrosine Kinase Inhibitors

by Toshio Kuwai, Toru Nakamura, Takamitsu Sasaki, Sun-Jin Kim, Dominic Fan, Gabriel J. Villares, Maya Zigler, Hua Wang, Menashe Bar-Eli, Robert S. Kerbel, Isaiah J. Fidler
Published 2008-05-01

Metronomic S-1 Chemotherapy and Vandetanib: An Efficacious and Nontoxic Treatment for Hepatocellular Carcinoma

by Hideki Iwamoto, Takuji Torimura, Toru Nakamura, Osamu Hashimoto, Kinya Inoue, Junichi Kurogi, Takashi Niizeki, Reiichiro Kuwahara, Mitsuhiko Abe, Hiromori Koga, Hirohisa Yano, Robert S. Kerbel, Takato Ueno, Michio Sata
Published 2011-03-01